Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors for cancer treatment.
第一作者:
John C,Dawson
第一单位:
Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
作者:
医学主题词
动物(Animals);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);人类(Humans);小鼠(Mice);丝裂原激活蛋白激酶激酶类(Mitogen-Activated Protein Kinase Kinases);肿瘤(Neoplasms);蛋白激酶抑制剂(Protein Kinase Inhibitors);喹唑啉类(Quinazolines);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1002/1878-0261.13151
PMID
34856074
发布时间
2025-05-30
基金项目
15703/CRUK_/Cancer Research UK/United Kingdom
C157/A15703/CRUK_/Cancer Research UK/United Kingdom
C157/A24837/CRUK_/Cancer Research UK/United Kingdom
C157/A1362/CRUK_/Cancer Research UK/United Kingdom
24837/CRUK_/Cancer Research UK/United Kingdom
- 浏览4
Molecular oncology
1072-1090页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



